NVOH vs. BPH

Last updated Apr 2, 2026

Compare and contrast key facts about Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and BP p.l.c. ADRhedged ETF (BPH).

NVOH and BPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. NVOH is an actively managed fund by Precidian. It was launched on Jan 2, 2025. BPH is an actively managed fund by Precidian. It was launched on Jan 3, 2025.

Performance

NVOH vs. BPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and BP p.l.c. ADRhedged ETF (BPH). The values are adjusted to include any dividend payments, if applicable.

NVOH vs. BPH - Yearly Performance Comparison

	2026 (YTD)	2025
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF	-24.75%	-42.98%
BPH BP p.l.c. ADRhedged ETF	35.03%	6.33%

Returns By Period

In the year-to-date period, NVOH achieves a -24.75% return, which is significantly lower than BPH's 35.03% return.

NVOH

• 1D: -1.00%
• 1M: 0.42%
• YTD: -24.75%
• 6M: -34.28%
• 1Y: -46.24%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BPH

• 1D: -1.67%
• 1M: 17.13%
• YTD: 35.03%
• 6M: 37.66%
• 1Y: 38.47%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVOH vs. BPH - Expense Ratio Comparison

Both NVOH and BPH have an expense ratio of 0.19%, making them cost-effective options compared to the broader market, where average expense ratios typically range from 0.3% to 0.9%.

NVOH

Novo Nordisk A/S (B Shares) ADRhedged ETF

BPH

BP p.l.c. ADRhedged ETF

Return for Risk

NVOH vs. BPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVOH

NVOH Risk / Return Rank: 1
NVOH Sharpe Ratio Rank: 1
NVOH Sortino Ratio Rank: 1
NVOH Omega Ratio Rank: 1
NVOH Calmar Ratio Rank: 1
NVOH Martin Ratio Rank: 1

BPH

BPH Risk / Return Rank: 59
BPH Sharpe Ratio Rank: 69
BPH Sortino Ratio Rank: 64
BPH Omega Ratio Rank: 62
BPH Calmar Ratio Rank: 60
BPH Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVOH vs. BPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and BP p.l.c. ADRhedged ETF (BPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVOH	BPH	Difference
Sharpe ratio Return per unit of total volatility	-0.88	1.30	-2.18
Sortino ratio Return per unit of downside risk	-1.14	1.72	-2.86
Omega ratio Gain probability vs. loss probability	0.84	1.24	-0.40
Calmar ratio Return relative to maximum drawdown	-0.89	1.74	-2.63
Martin ratio Return relative to average drawdown	-1.51	4.47	-5.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVOH vs. BPH - Sharpe Ratio Comparison

The current NVOH Sharpe Ratio is -0.88, which is lower than the BPH Sharpe Ratio of 1.30. The chart below compares the historical Sharpe Ratios of NVOH and BPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NVOH	BPH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.88	1.30	-2.18
Sharpe Ratio (All Time) Calculated using the full available price history	-0.98	1.19	-2.17

Correlation

The correlation between NVOH and BPH is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVOH vs. BPH - Dividend Comparison

NVOH's dividend yield for the trailing twelve months is around 4.56%, more than BPH's 1.88% yield.

	TTM	2025
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF	4.56%	2.38%
BPH BP p.l.c. ADRhedged ETF	1.88%	1.74%

Drawdowns

NVOH vs. BPH - Drawdown Comparison

The maximum NVOH drawdown since its inception was -61.60%, which is greater than BPH's maximum drawdown of -26.32%. Use the drawdown chart below to compare losses from any high point for NVOH and BPH.

Drawdown Indicators

	NVOH	BPH	Difference
Max Drawdown Largest peak-to-trough decline	-61.60%	-26.32%	-35.28%
Max Drawdown (1Y) Largest decline over 1 year	-53.00%	-22.08%	-30.92%
Current Drawdown Current decline from peak	-60.40%	-3.05%	-57.35%
Average Drawdown Average peak-to-trough decline	-36.02%	-7.52%	-28.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.21%	8.61%	+22.60%

Volatility

NVOH vs. BPH - Volatility Comparison

Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and BP p.l.c. ADRhedged ETF (BPH) have volatilities of 8.19% and 8.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVOH	BPH	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.19%	8.56%	-0.37%
Volatility (6M) Calculated over the trailing 6-month period	37.53%	19.50%	+18.03%
Volatility (1Y) Calculated over the trailing 1-year period	52.51%	29.60%	+22.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	51.04%	28.79%	+22.25%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.04%	28.79%	+22.25%